FSHIP2 regulates epithelial cell polarity through its lipid product, which binds to Dlg1, a pathway subverted by hepatitis C virus core protein

Molecular Biology of the Cell

Volumn 24, Issue 14, 2013, Pages 2171-2185

  Awad, Aline ^a,b   Sar, Sokhavuth ^a,b   Barré, Ronan ^c   Cariven, Clotilde ^c   Marin, Mickael ^a,b   Salles, Jean Pierre ^c   Erneux, Christophe ^d   Samuel, Didier ^a,b,e   Gassama Diagne, Ama ^a,b  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b Universite Paris Sud   (France)

^c UNIVERSITÉ PAUL SABATIER   (France)

^d UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^e HÔPITAL PAUL BROUSSE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CORE PROTEIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE; PROTEIN DLG 1; PROTEIN SH2; RAC1 PROTEIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SH2 DOMAIN CONTAINING INOSITOL PHOSPHATE 5 PHOSPHATASE 2; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; DLG1 PROTEIN, HUMAN; INPPL1 PROTEIN, HUMAN; ISOPROTEIN; MEMBRANE PROTEIN; PHOSPHATASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5-TRIPHOSPHATE; PHOSPHATIDYLINOSITOL-3-PHOSPHATASE; POLYPHOSPHOINOSITIDE; SIGNAL TRANSDUCING ADAPTOR PROTEIN; PHOSPHATIDYLINOSITOL 3 PHOSPHATASE;

ANIMAL CELL; ARTICLE; BASOLATERAL MEMBRANE; CELL MEMBRANE; CELL POLARITY; CONTROLLED STUDY; ENZYME ACTIVITY; EPITHELIUM CELL; HEPATITIS C VIRUS; LIPID METABOLISM; LIVER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; VIRUS NUCLEOCAPSID; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL LINE; DOG; GENE EXPRESSION REGULATION; GENETICS; HEPACIVIRUS; HOST PATHOGEN INTERACTION; HUMAN; METABOLISM; PHYSIOLOGY; VIROLOGY; DRUG ANTAGONISM;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; CELL LINE; CELL POLARITY; DOGS; EPITHELIAL CELLS; GENE EXPRESSION REGULATION; HEPACIVIRUS; HEPATOCYTES; HOST-PATHOGEN INTERACTIONS; HUMANS; MEMBRANE PROTEINS; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHATIDYLINOSITOL 4,5-DIPHOSPHATE; PHOSPHATIDYLINOSITOL PHOSPHATES; PHOSPHORIC MONOESTER HYDROLASES; PROTEIN ISOFORMS; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; VIRAL CORE PROTEINS;

EID: 84880446135     PISSN: 10591524     EISSN: 19394586     Source Type: Journal    
DOI: 10.1091/mbc.E12-08-0626     Document Type: Article

References (80)

1. Alvisi G, Madan V, Bartenschlager R (2011). Hepatitis C virus and host cell lipids: an intimate connection. RNA Biol 8, 258-269.
2. Backers K, Blero D, Paternotte N, Zhang J, Erneux C (2003). The termination of PI3K signalling by SHIP1 and SHIP2 inositol 5-phosphatases. Adv Enzyme Regul 43, 15-28.
3. Barba G et al. (1997). Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets. Proc Natl Acad Sci USA 94, 1200-1205.
4. Bartenschlager R, Penin F, Lohmann V, André P (2011). Assembly of infectious hepatitis C virus particles. Trends Microbiol 19, 95-103.
5. Battaglia S, Benzoubir N, Nobilet S, Charneau P, Samuel D, Zignego AL, Atfi A, Bréchot C, Bourgeade MF (2009). Liver cancer-derived hepatitis C virus core proteins shift TGF-beta responses from tumor suppression to epithelial-mesenchymal transition. PLoS One 4, e4355.
6. Benedicto I, Molina-Jiménez F, Barreiro O, Maldonado- Rodríguez A, Prieto J, Moreno-Otero R, Aldabe R, López-Cabrera M, Majano PL (2008). Hepatitis C virus envelope components alter localization of hepatocyte tight junction-associated proteins and promote occludin retention in the endoplasmic reticulum. Hepatology 48, 1044-1053.
7. Benedicto I, Molina-Jiménez F, Moreno-Otero R, López-Cabrera M, Majano PL (2011). Interplay among cellular polarization, lipoprotein metabolism and hepatitis C virus entry. World J Gastroenterol 17, 2683-2690.
8. Berger KL, Cooper JD, Heaton NS, Yoon R, Oakland TE, Jordan TX, Mateu G, Grakoui A, Randall G (2009). Roles for endocytic trafficking and phosphatidylinositol 4-kinase III alpha in hepatitis C virus replication. Proc Natl Acad Sci USA 106, 7577-7582.
9. Berger KL, Kelly SM, Jordan TX, Tartell MA, Randall G (2011). Hepatitis C virus stimulates the phosphatidylinositol 4-kinase III alpha-dependent phosphatidylinositol 4-phosphate production that is essential for its replication. J Virol 85, 8870-8883.
10. Bianco A et al. (2012). Metabolism of phosphatidylinositol 4-kinase IIIα-dependent PI4P Is subverted by HCV and is targeted by a 4-anilino quinazoline with antiviral activity. PLoS Pathog 8, e1002576.
11. Borawski J et al. (2009). Class III phosphatidylinositol 4-kinase alpha and beta are novel host factor regulators of hepatitis C virus replication. J Virol 83, 10058-10074.
12. Boudreau NJ, Jones PL (1999). Extracellular matrix and integrin signalling: the shape of things to come. Biochem J 339, 481-488.
13. Boulant S, Douglas MW, Moody L, Budkowska A, Targett-Adams P, McLauchlan J (2008). Hepatitis C virus core protein induces lipid droplet redistribution in a microtubule- and dynein-dependent manner. Traffic 9, 1268-1282.
14. Burridge K, Wennerberg K (2004). Rho and Rac take center stage. Cell 116, 167-179.
15. Brown MC, Turner CE (2004). Paxillin: adapting to change. Physiol Rev 84, 1315-1339.
16. Bryant DM, Mostov KE (2008). From cells to organs: building polarized tissue. Nat Rev Mol Cell Biol 9, 887-901.
17. Cantley LC (2002). The phosphoinositide 3-kinase pathway. Science 296, 1655-1657.
18. Comer FI, Parent CA (2007). Phosphoinositides specify polarity during epithelial organ development. Cell 128, 239-240.
19. Cossart P (2011). Illuminating the landscape of host-pathogen interactions with the bacterium Listeria monocytogenes. Proc Natl Acad Sci USA 108, 19484-19491.
20. Dyson JM, O'Malley CJ, Becanovic J, Munday AD, Berndt MC, Coghill ID, Nandurkar HH, Ooms LM, Mitchell CA (2001). The SH2-containing inositol polyphosphate 5-phosphatase, SHIP-2, binds filamin and regulates submembraneous actin. J Cell Biol 155, 1065-1079.
21. Erneux C, Edimo WE, Deneubourg L, Pirson I (2011). SHIP2 multiple functions: a balance between a negative control of PtdIns(3,4,5)P3 level, a positive control of PtdIns(3,4)P2 production, and intrinsic docking properties. J Cell Biochem 112, 2203-2209.
22. Elong Edimo W, Vanderwinden JM, Erneux C (2013). SHIP2 signalling at the plasma membrane, in the nucleus and at focal contacts. Adv Biol Regul 53, 28-37.
23. Gassama-Diagne A, Payrastre B (2009). Phosphoinositide signaling pathways: promising role as builders of epithelial cell polarity. Int Rev Cell Mol Biol 273, 313-343.
24. Gassama-Diagne A, Yu W, ter Beest M, Martin-Belmonte F, Kierbel A, Engel J, Mostov K (2006). Phosphatidylinositol-3,4,5-trisphosphate regulates the formation of the basolateral plasma membrane in epithelial cells. Nat Cell Biol 8, 963-970.
25. Herker E, Harris C, Hernandez C, Carpentier A, Kaehlcke K, Rosenberg AR, Farese RV Jr, Ott M (2010). Efficient hepatitis C virus particle formation requires diacylglycerol acyltransferase-1. Nat Med 16, 1295-1298.
26. Huber C et al. (2013). Exome sequencing identifies INPPL1 mutations as a cause of opsismodysplasia. Am J Hum Genet 92, 144-149.
27. Icard V, Diaz O, Scholtes C, Perrin-Cocon L, Ramière C, Bartenschlager R, Penin F, Lotteau V, André P (2009). Secretion of hepatitis C virus envelope glycoproteins depends on assembly of apolipoprotein B positive lipoproteins. PLoS One 4, e4233.
28. Jones DM, McLauchlan J (2010). Core is associated with different steps of HCV assembly. J Biol Chem 285, 22733-22739.
29. Kanda T, Yokosuka O, Mikata R, Zhang KY, Tanaka M, Tada M, Fukai K, Imazeki F, Saisho H (2007). Inhibition of subgenomic hepatitis C virus RNA replication in HeLa cells. Hepatogastroenterology 54, 32-35.
30. Kapadia SB, Chisari FV (2005). Hepatitis C virus RNA replication is regulated by host geranylgeranylation and fatty acids. Proc Natl Acad Sci USA 102, 2561-2566.
31. Kato K et al. (2012). The inositol 5-phosphataseSHIP2 is an effector of RhoA and is involved in cell polarity and migration. Mol Biol Cell 23, 2593-2604.
32. Kato T, Date T, Miyamoto M, Zhao Z, Mizokami M, Wakita T (2005). Nonhepatic cell lines HeLa and 293 support efficient replication of the hepatitis C virus genotype 2a subgenomic replicon. J Virol 79, 592-596.
33. Kazmierczak BI, Mostov K, Engel JN (2001). Interactions of bacteria pathogens with polarized epithelium. Annu Rev Microbiol 55, 407-435.
34. Krahn MP, Klopfenstein DR, Fischer N, Wodarz A (2010). Membrane targeting of Bazooka/PAR-3 is mediated by direct binding to phosphoinositide lipids. Curr Biol 20, 636-642.
35. Kunkel M, Watowich SJ (2004). Biophysical characterization of hepatitis C virus core protein: implications for interactions within the virus and host. FEBS Lett 557, 174-180.
36. Liu S, Yang W, Shen L, Turner JR, Coyne CB, Wang T (2009). Tight junction proteins claudin-1 and occludin control hepatitis virus entry and are downregulated during infection to prevent superinfection. J Virol 83, 2011-2014.
37. Marion E et al. (2002). The gene INPPL1, encoding the lipid phosphatase SHIP2, is a candidate for type 2 diabetes in rat and man. Diabetes 51, 2012-2017.
38. Martin S, Parton RG (2006). Lipid droplets: a unified view of a dynamic organelle. Nat Cell Biol 9, 1089-1097.
39. Martin-Belmonte F, Gassama A, Datta A, Yu W, Rescher U, Gerke V, Mostov K (2007). PTEN-mediated apical segregation of phosphoinositides controls epithelial morphogenesis through Cdc42. Cell 128, 383-397.
40. Mee CJ, Farquhar MJ, Harris HJ, Hu K, Ramma W, Ahmed A, Maurel P, Bicknell R, Balfe P, McKeating JA (2010). Hepatitis C virus infection reduces hepatocellular polarity in a vascular endothelial growth factor-dependent manner. Gastroenterology 138, 1134-1142.
41. Mee CJ, Grove J, Harris HJ, Hu K, Balfe P, McKeating JA (2008). Effect of cell polarization on hepatitis C virus entry. J Virol 82, 461-470.
42. Mee CJ, Harris HJ, Farquhar MJ, Wilson G, Reynolds G, Davis C, van IJzendoorn SC, Balfe P, McKeating JA (2009). Polarization restricts hepatitis C virus entry into HepG2 hepatoma cells. J Virol 83, 6211-6221.
43. McNulty S, Powell K, Erneux C, Kalman D (2011). The host phosphoinositide 5-phosphatase SHIP2 regulates dissemination of vaccinia virus. J Virol 85, 7402-7410.
44. Mellman I, Nelson WJ (2008). Coordinated protein sorting, targeting and distribution in polarized cells. Nat Rev Mol Cell Biol 9, 833-845.
45. Miyanari Y, Atsuzawa K, Usuda N, Watashi K, Hishiki T, Zayas M, Bartenschlager R, Wakita T, Hijikata M, Shimotohno K (2007). The lipid droplet is an important organelle for hepatitis C virus production. Nat Cell Biol 9, 1089-1097.
46. Moradpour D et al. (2007). Replication of hepatitis C virus. Nat Rev Microbiol 5, 453-463.
47. Moriya K, Yotsuyanagi H, Shintani Y, Fujie H, Ishibashi K, Matsuura Y, Miyamura T, Koike K (1997). Hepatitis C viruscore protein induces hepatic steatosis in transgenic mice. J Gen Virol 78, 1527-1531.
48. Moriya K et al. (2001). Oxidative stress in the absence of inflammation in a mouse model for hepatitis C virus-associated hepatocarcinogenesis. Cancer Res 61, 4365-4370.
49. Muthuswamy SK, Xue B (2012). Cell polarity as a regulator of cancer cell behavior plasticity. Annu Rev Cell Dev Biol 27, 1-27.
50. Nelson WJ (2003). Adaptation of core mechanisms to generate cell polarity. Nature 422, 766-774.
51. Nishio M et al. (2007). Control of cell polarity and motility by the PtdIns(3,4,5)P3 phosphatase SHIP1. Nat Cell Biol 9, 36-44.
52. O'Brien LE, Jou TS, Pollack AL, Zhang Q, Hansen SH, Yurchenco P, Mostov KE (2001). Rac1 orientates epithelial apical polarity through effects on basolateral laminin assembly. Nat Cell Biol 3, 831-838.
53. Olofsson SO, Boström P, Andersso l, Rutberg M, Perman J, Borén J (2009). Lipid droplets as dynamic organelles connecting storage and efflux of lipids. Biochim Biophys Acta 1791, 448-458.
54. Ooms LM, Horan KA, Rahman P, Seaton G, Gurung R, Kethesparan DS, Mitchell CA (2009). The role of the inositol polyphosphate 5-phosphatases in cellular function and human disease. Biochem J 419, 29-49.
55. Paternotte N, Zhang J, Vandenbroere I, Backers K, Blero D, Kioka N, Vanderwinden JM, Pirson I, Erneux C (2005). SHIP2 interaction with the cytoskeletal protein Vinexin. FEBS J 272, 6052-6066.
56. Pavio N, Battaglia S, Boucreux D, Arnulf B, Sobesky R, Hermine O, Brechot C (2005). Hepatitis C virus core variants isolated from liver tumor but not from adjacent non-tumor tissue interact with Smad3 and inhibit the TGF-beta pathway. Oncogene 24, 6119-6132.
57. Pesesse X, Deleu S, De Smedt F, Drayer L, Erneux C (1997). Identification of a second SH2-domain-containing protein closely related to the phosphatidylinositol polyphosphate 5-phosphatase SHIP. Biochem Biophys Res Commun 239, 697-700.
58. Pesesse X, Dewaste V, De Smedt F, Laffargue M, Giuriato S, Moreau C, Payrastre B, Erneux C (2001). The Src homology 2 domain containing inositol 5-phosphatase SHIP2 is recruited to the epidermal growth factor (EGF) receptor and dephosphorylates phosphatidylinositol 3,4,5-trisphosphate in EGF-stimulated COS-7 cells. J Biol Chem 276, 28348-28355.
59. Perlemuter et al. (2002). Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral-related steatosis. FASEB J 16, 185-194.
60. Phillipson M, Kubes P (2011). The neutrophil in vascular inflammation. Nat Med 17, 1381-1390.
61. Ploss A, Evans MJ, Gaysinskaya VA, Panis M, You H, de Jong YP, Rice CM (2009). Human occludin is a hepatitis C virus entry factor required for infection of mouse cells. Nature 457, 882-886.
62. Prasad N, Topping RS, Decker SJ (2001). SH2-containing inositol 5′-phosphatase SHIP2 associates with the p130(Cas) adapter protein and regulates cellular adhesion and spreading. Mol Cell Biol 21, 1416-1428.
63. Prasad NK, Tandon M, Badve S, Snyder PW, Nakshatri H (2008). Phosphoinositol phosphatase SHIP2 promotes cancer development and metastasis coupled with alterations in EGF receptor turnover. Carcinogenesis 29, 25-34.
64. Reiss S et al. (2011). Recruitment and activation of a lipid kinase by hepatitis C virus NS5A is essential for integrity of the membranous replication compartment. Cell Host Microbe 9, 32-45.
65. Rice CM (2011). New insights into HCV replication; potential antiviral targets. Top Antivir Med 19, 117-120.
66. Rodriguez-Boulan E, Paskiet KT, Sabatini DD (1983). Assembly of enveloped viruses in Madin-Darby canine kidney cells: polarized budding from single attached cells and from clusters of cells in suspension. J Cell Biol 96, 866-874.
67. Roe B, Kensicki E, Mohney R, Hall WW (2011). Metabolomic profile of hepatitis C virus-infected hepatocytes. PLoS One 6, e23641.
68. Shewan A, Eastburn DJ, Mostov K (2011). Phosphoinositides in cell architecture. Cold Spring Harb Perspect Biol 3, a004796.
69. Sleeman MW et al. (2005). Absence of the lipid phosphatase SHIP2 confers resistance to dietary obesity. Nat Med 11, 199-205.
70. Snooks MJ, Bhat P, Mackenzie J, Counihan NA, Vaughan N, Anderson DA (2008). Vectorial entry and release of hepatitis A virus in polarized human hepatocytes. J Virol 82, 8733-8742.
71. Stenzel N, Fetzer CP, Heumann R, Erdmann KS (2009). PDZ-domain-directed basolateral targeting of the peripheral membrane protein FRMPD2 in epithelial cells. J Cell Sci 122, 3374-3384.
72. Sumie S et al. (2007). Significance of glucose intolerance and SHIP2 expression in hepatocellular carcinoma patients with HCV infection. Oncol Rep 3, 545-552.
73. Trotard M, Lepère-Douard C, Régeard M, Piquet-Pellorce C, Lavillette D, Cosset FL, Gripon P, Le Seyec J (2009). Kinases required in hepatitis C virus entry and replication highlighted by small interference RNA screening. FASEB J 23, 3780-3789.
74. Wodarz A (2002). Establishing cell polarity in development. Nat Cell Biol 4, E39-E44.
75. Wu H, Feng W, Chen J, Chan LN, Huang S, Zhang M (2007). PDZ domains of Par-3 as potential phosphoinositide signaling integrators. Mol Cell 28, 886-898.
76. Wullschleger S, Wasserman DH, Gray A, Sakamoto K, Alessi DR (2011). Role of TAPP1 and TAPP2 adaptor binding to PtdIns(3,4)P2 in regulating insulin sensitivity defined by knock-in analysis. Biochem J 434, 265-274.
77. Xie J, Onnockx S, Vandenbroere I, Degraef C, Erneux C, Pirson I (2008). The docking properties of SHIP2 influence both JIP1 tyrosine phosphorylation and JNK activity. Cell Signal 20, 1432-1441.
78. Yu W, Shewan AM, Brakeman P, Eastburn DJ, Datta A, Bryant DM, Fan QW, Weiss WA, Zegers MM, Mostov KE (2008). Involvement of RhoA, ROCK I and myosin II in inverted orientation of epithelial polarity. EMBO Rep 9, 923-929.
79. Zhang J, Liu Z, Rasschaert J, Blero D, Deneubourg L, Schurmans S, Erneux C, Pesesse X (2007). SHIP2 controls PtdIns(3,4,5)P3 levels and PKB activity in response to oxydative stress. Cell Signal 19, 2194-2200.
80. Zwaenepoel K, Goris J, Erneux C, Parker PJ, Janssens V (2010). Protein phosphatase 2A PR130/B''alpha1 subunit binds to the SH2 domain-containing inositol polyphosphate 5-phosphatase 2 and prevents epidermal growth factor (EGF)-induced EGF receptor degradation sustaining EGF-mediated signaling. FASEB J 24, 538-547.